Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475513 · ClinicalTrials.gov registry record · Phase 4
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 4
- Development phase
- 47
- Enrollment target
NCT01475513 is a Phase 4 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 47 participants.
The verdict
NCT01475513, a Phase 4 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 47 participants
- Enrollment target
Study Summary
Birth control pills are the most commonly used method of birth control. The purpose of this research study is to examine whether birth control pills change heart disease risk and how the body handles blood sugar when given to different women.
Interventions
- DRUG Ortho Cyclen®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-05-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01475513
The ClinicalTrials.gov registry entry for NCT01475513 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ortho Cyclen® is the first listed.
NCT01475513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01475513 about?
NCT01475513 is a clinical study titled "Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women". Birth control pills are the most commonly used method of birth control. The purpose of this research study is to examine whether birth control pills change heart disease risk and how the body handles blood sugar when given to different women.
What is the current status of trial NCT01475513?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 47 participants. The study started on 2011-11. Estimated completion is 2014-05-28.
What interventions are being tested in trial NCT01475513?
The interventions under investigation include: Ortho Cyclen® (DRUG).
Who is sponsoring clinical trial NCT01475513?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.